In the world of peptide therapies, BPC-157 and TB-500 have gained attention for their potential in promoting healing and recovery
Gastrointestinal symptomsparticularly nausea, vomiting, diarrhoea, and constipationare the most frequently reported adverse effects of GLP-1 receptor agonists, occurring in 2050% of patients depending on the specific agent and dose according to clinical trials and SmPC data
But how, exactly
These combinations are theoretical and require medical supervision, but they represent a practical path forward while peptide-specific evidence accumulates
Research peptides are synthesized to a defined purity and identity specification for laboratory use, verified by analytical chemistry rather than clinical trials
The dose of Epitalon used was 5 mg, subcutaneously for 10 consecutive days (one vial contained 50 mg of Epitalon)